PVH vs XERS · P/E 24, rev $8.95B vs rev $175.2M
PVH Corp (PVH) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
PVH Corp (PVH) is a apparel manufacturing company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported PVH revenue for 2026-02-01 was $8.95B. Net income was $25.3M. Revenue was up 3.4% from 2025-02-02 to 2026-02-01. PVH currently screens at market cap $3.60B and trailing P/E 23.7.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
PVH currently screens at market cap $3.60B and trailing P/E 23.7. XERS currently screens at market cap $760.7M.
Not investment advice. Open the PVH and XERS stock pages for the full models.
Not investment advice.